Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Liberty - Outstanding Awards (Details)

v3.19.1
Stock-Based Compensation - Liberty - Outstanding Awards (Details)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2019
USD ($)
$ / shares
shares
Additional disclosures  
Total unrecognized compensation cost related to unvested equity awards | $ $ 39
Weighted average period of recognition related to unvested equity awards (in years) 1 year 3 months 18 days
Liberty Sirius XM Group  
Additional disclosures  
Common stock reserved for issuance 13,300,000
Liberty Sirius XM Group | Common Class A  
Number of options  
Outstanding at beginning of period 1,403,000
Granted 0
Exercised (61,000)
Outstanding at end of period 1,342,000
Exercisable at end of period 1,339,000
WAEP  
Outstanding at beginning of period | $ / shares $ 19.84
Exercised | $ / shares 19.51
Outstanding at end of period | $ / shares 19.85
Exercisable at end of period | $ / shares $ 19.83
Additional disclosures  
Weighted average remaining life, outstanding 8 months 12 days
Weighted average remaining life, exercisable 8 months 12 days
Aggregate intrinsic value, outstanding | $ $ 25
Aggregate intrinsic value, exercisable | $ $ 25
Liberty Sirius XM Group | Common Class C  
Number of options  
Outstanding at beginning of period 11,495,000
Granted 491,000
Exercised (75,000)
Outstanding at end of period 11,911,000
Exercisable at end of period 8,059,000
WAEP  
Outstanding at beginning of period | $ / shares $ 28.85
Granted | $ / shares 40.53
Exercised | $ / shares 19.65
Outstanding at end of period | $ / shares 29.39
Exercisable at end of period | $ / shares $ 28.48
Additional disclosures  
Weighted average remaining life, outstanding 3 years 3 months 18 days
Weighted average remaining life, exercisable 2 years 10 months 24 days
Aggregate intrinsic value, outstanding | $ $ 110
Aggregate intrinsic value, exercisable | $ $ 82
Braves Group  
Additional disclosures  
Common stock reserved for issuance 1,400,000
Braves Group | Common Class A  
Number of options  
Outstanding at beginning of period 177,000
Granted 0
Exercised (5,000)
Outstanding at end of period 172,000
Exercisable at end of period 172,000
WAEP  
Outstanding at beginning of period | $ / shares $ 11.44
Exercised | $ / shares 11.42
Outstanding at end of period | $ / shares 11.44
Exercisable at end of period | $ / shares $ 11.42
Additional disclosures  
Weighted average remaining life, outstanding 8 months 12 days
Weighted average remaining life, exercisable 8 months 12 days
Aggregate intrinsic value, outstanding | $ $ 3
Aggregate intrinsic value, exercisable | $ $ 3
Braves Group | Common Class C  
Number of options  
Outstanding at beginning of period 1,276,000
Granted 7,000
Exercised (15,000)
Outstanding at end of period 1,268,000
Exercisable at end of period 919,000
WAEP  
Outstanding at beginning of period | $ / shares $ 16.58
Granted | $ / shares 27.73
Exercised | $ / shares 11.52
Outstanding at end of period | $ / shares 16.70
Exercisable at end of period | $ / shares $ 16.49
Additional disclosures  
Weighted average remaining life, outstanding 3 years
Weighted average remaining life, exercisable 2 years 9 months 18 days
Aggregate intrinsic value, outstanding | $ $ 14
Aggregate intrinsic value, exercisable | $ $ 10
Formula One Group  
Additional disclosures  
Common stock reserved for issuance 9,300,000
Formula One Group | Common Class A  
Number of options  
Outstanding at beginning of period 360,000
Granted 0
Outstanding at end of period 360,000
Exercisable at end of period 360,000
WAEP  
Outstanding at beginning of period | $ / shares $ 11.71
Outstanding at end of period | $ / shares 11.71
Exercisable at end of period | $ / shares $ 11.70
Additional disclosures  
Weighted average remaining life, outstanding 8 months 12 days
Weighted average remaining life, exercisable 8 months 12 days
Aggregate intrinsic value, outstanding | $ $ 8
Aggregate intrinsic value, exercisable | $ $ 8
Formula One Group | Common Class C  
Number of options  
Outstanding at beginning of period 6,684,000
Granted 2,231,000
Outstanding at end of period 8,915,000
Exercisable at end of period 5,403,000
WAEP  
Outstanding at beginning of period | $ / shares $ 26.92
Granted | $ / shares 33.94
Outstanding at end of period | $ / shares 28.67
Exercisable at end of period | $ / shares $ 27.95
Additional disclosures  
Weighted average remaining life, outstanding 5 years 1 month 6 days
Weighted average remaining life, exercisable 4 years 6 months
Aggregate intrinsic value, outstanding | $ $ 57
Aggregate intrinsic value, exercisable | $ $ 38